Stowers Institute Secured Federal Protein Research Funding
The Kansas City lab received $4.1 million to help launch a project using artificial intelligence for disease study.
Updated on Oct. 10, 2026 in Diseases — General

Live Poll
Should medical researchers prioritize using artificial intelligence to detect neurodegenerative diseases earlier?
The Stowers Institute for Medical Research has received $4.1 million in federal funding to generate data on protein aggregation. This work supports the broader NATIVE-ID project, which utilizes artificial intelligence to predict protein dysfunction in diseases like frontotemporal lobar degeneration.
Why it matters
Current artificial intelligence models lack sufficient high-quality data to accurately predict how intrinsically disordered proteins behave. This research aims to bridge that gap to improve future therapeutic discovery and diagnostic methods.
The NATIVE-ID project will analyze 50,000 individual proteins to produce more than 10 billion measurements of protein aggregation. The research relies on Distributed Amphifluoric FRET technology to monitor self-assembly inside living yeast cells.
The players
Stowers Institute for Medical Research
This is a non-profit biomedical research organization based in Kansas City that focuses on basic research to improve human health.
ARPA-H
The Advanced Research Projects Agency for Health is a federal agency that funds high-impact biomedical and health research projects.
Randal Halfmann
He is a lead researcher at the Stowers Institute who specializes in protein assembly and amyloid structures.
The details
Researchers will spend 24 months generating foundational datasets to teach AI systems how protein dysfunction occurs at a molecular level. By focusing initially on frontotemporal lobar degeneration, the team hopes to establish a template for studying other protein-related diseases.
Timeline
2015: Randal Halfmann joined the Stowers Institute.
2018: The DAmFRET technology was developed.
2023: Halfmann's lab determined the structure of amyloid formation.
October 9, 2026: The research project was announced.
Deeper Dive
This effort follows the trajectory set by the NATIVE-ID project to revolutionize protein science through high-throughput experimental data. It marks a departure from traditional, low-volume protein analysis by utilizing large-scale machine learning.
This project provides the foundational data necessary to develop more effective diagnostic tools and potential therapies for neurodegenerative conditions. While currently in the research phase, these advancements could eventually lead to earlier clinical detection and personalized treatment paths for patients.
The takeaway
This research highlights the growing reliance on artificial intelligence to solve complex biological puzzles that were previously too vast for human observation. By generating massive amounts of molecular data, scientists are building the infrastructure required for the next generation of precision medicine.
Further reading
Learn more about the latest developments in medical research within our Diseases — General section.
Live Poll
Should medical researchers prioritize using artificial intelligence to detect neurodegenerative diseases earlier?










